Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT02107846 | An Open-Label, Dose Escalation Study to Evaluate the Safety and the Pharmacokinetics of Oral PRX-112 | PHASE2 | COMPLETED | 10 | — | — | Apr 1, 2014 | Dec 1, 2015 | Sep 27, 2016 | - | — |
| NCT01747980 | Safety and Pharmacokinetics of Oral PRX-112 in Gaucher Disease Patients | PHASE1 | COMPLETED | 16 | — | — | Mar 1, 2013 | Mar 1, 2014 | Apr 6, 2014 | - | — |
| Name | Type | Description |
|---|---|---|
| PRX-112 | DRUG | - |